Document Details
Form
Filing Date
November 6, 2023
Document Date
September 30, 2023
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.